SIC
TMO icon

Salem Investment Counselors’s Thermo Fisher Scientific TMO Stock Holding History

Salem Investment Counselors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.71M Buy
17,376
+414
+2% +$199K 0.22% 65
2026
Q1 		$8.34M Buy
16,962
+502
+3% +$272K 0.24% 65
2025
Q4 		$9.54M Sell
16,460
-1,648
-9% -$932K 0.27% 56
2025
Q3 		$8.78M Buy
18,108
+1,034
+6% +$481K 0.25% 59
2025
Q2 		$6.92M Sell
17,074
-1,748
-9% -$731K 0.22% 76
2025
Q1 		$9.37M Buy
18,822
+1,158
+7% +$627K 0.33% 53
2024
Q4 		$9.19M Buy
17,664
+930
+6% +$511K 0.3% 51
2024
Q3 		$10.4M Sell
16,734
-21
-0.1% -$12.4K 0.31% 52
2024
Q2 		$9.27M Sell
16,755
-305
-2% -$175K 0.3% 53
2024
Q1 		$9.92M Buy
17,060
+1,996
+13% +$1.12M 0.33% 52
2023
Q4 		$8M Sell
15,064
-5,529
-27% -$2.68M 0.27% 56
2023
Q3 		$10.4M Buy
20,593
+2,215
+12% +$1.18M 0.4% 46
2023
Q2 		$9.6M Buy
18,378
+1,795
+11% +$969K 0.35% 49
2023
Q1 		$9.56M Buy
16,583
+9,888
+148% +$5.57M 0.38% 46
2022
Q4 		$3.69M Buy
6,695
+3,060
+84% +$1.62M 0.16% 91
2022
Q3 		$1.84M Buy
3,635
+47
+1% +$26.3K 0.08% 131
2022
Q2 		$1.95M Sell
3,588
-1
-0% -$550 0.09% 132
2022
Q1 		$2.12M Sell
3,589
-531
-13% -$305K 0.08% 132
2021
Q4 		$2.75M Buy
4,120
+177
+4% +$111K 0.1% 116
2021
Q3 		$2.25M Buy
3,943
+872
+28% +$479K 0.12% 131
2021
Q2 		$1.55M Buy
3,071
+318
+12% +$150K 0.09% 150
2021
Q1 		$1.26M Buy
2,753
+126
+5% +$60.1K 0.08% 151
2020
Q4 		$1.22M Buy
2,627
+247
+10% +$116K 0.08% 143
2020
Q3 		$1.05M Buy
2,380
+1,354
+132% +$559K 0.08% 142
2020
Q2 		$372K Buy
1,026
+36
+4% +$12.1K 0.03% 199
2020
Q1 		$281K Buy
990
+73
+8% +$23K 0.03% 204
2019
Q4 		$298K Buy
917
+17
+2% +$5.16K 0.02% 222
2019
Q3 		$262K Buy
900
+390
+76% +$112K 0.02% 224
2019
Q2 		$150K Hold
510
– – 0.01% 267
2019
Q1 		$124K Buy
+510
New +$127K 0.01% 226
2018
Q4 		– Sell
-510
Closed -$124K – 369
2018
Q3 		$124K Hold
510
– – 0.01% 226
2018
Q2 		$106K Buy
510
+200
+65% +$42.5K 0.01% 231
2018
Q1 		$63K Hold
310
– – 0.01% 266
2017
Q4 		$59K Buy
310
+60
+24% +$11.5K 0.01% 296
2017
Q3 		$48K Sell
250
-30
-11% -$5.43K 0.01% 310
2017
Q2 		$49K Buy
280
+30
+12% +$5.04K 0.01% 318
2017
Q1 		$39K Sell
250
-36
-13% -$5.5K ﹤0.01% 409
2016
Q4 		$40K Buy
286
+36
+14% +$5.31K ﹤0.01% 379
2016
Q3 		$398 Buy
+250
New +$38.5K 0.01% 337

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Salem Investment Counselors's TMO Position: Q2 2026 in Review

Salem Investment Counselors increased its Thermo Fisher Scientific (TMO) stake by 2.4% in Q2 2026, buying an estimated $199K and bringing the position to 17,376 shares worth $8.71M. The position accounts for 0.22% of the portfolio, ranked #65.

Salem Investment Counselors first reported a position in TMO in Q3 2016 and has held it in 39 quarters since. The position peaked at $10.4M in Q3 2023. 1,237 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Salem Investment Counselors held 17,376 shares of Thermo Fisher Scientific worth $8.71M as of Q2 2026.
  • Salem Investment Counselors bought 414 Thermo Fisher Scientific shares in Q2 2026, an estimated $199K.
  • Thermo Fisher Scientific made up 0.22% of Salem Investment Counselors's portfolio in Q2 2026, its #65 holding.
  • Salem Investment Counselors first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 39 quarters since.
  • Salem Investment Counselors's Thermo Fisher Scientific position peaked at $10.4M in Q3 2023.
  • 1,237 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.